USA – Pfizer has terminated its collaboration with Ionis for the cholesterol-lowering therapy vupanorsen, following a review of phase 2b data that raised concerns about the antisense drug’s efficacy and…
Read MorePfizer backs out of vupanorsen development, hands back rights to partner Ionis
